Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001649094-25-000002
Filing Date
2025-01-03
Accepted
2025-01-03 18:07:22
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1735945636.html 4  
1 FORM 4 wk-form4_1735945636.xml 4 11297
  Complete submission text file 0001649094-25-000002.txt   12832
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VAXCYTE, INC. 353 HATCH DRIVE FOSTER CITY CA 94404
Business Address
Wassil Jim (Reporting) CIK: 0001813798 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 25508332